8 hrs ago
New Meds-New Hope For IBD
One point four million Americans suffer from inflammatory bowel diseases like Crohn's and ulcerative colitis.
11 hrs ago
The CementBloc Wins a Gold and 2 Bronzes at the 2013 CLIO Healthcare Awards
The Gold CLIO is in the digital category, for a website The Bloc created on behalf of Girls Right of Way , a nonprofit grassroots organization that helps at-risk girls realize their full potential.
Tue Dec 03, 2013
Medical News Today
New approach for growing intestinal stem cells
Researchers at MIT and Brigham and Women's Hospital have shown that they can grow unlimited quantities of intestinal stem cells , then stimulate them to develop into nearly pure populations of different types of mature intestinal cells.
Mon Dec 02, 2013
Crohn's Disease & Ulcerative Colitis Costs the US in the Billions
The estimated direct cost for all patients with inflammatory bowel diseases in the US is $1.84 billion.
Bedford senior battling cancer
Lauren Yates, a Bedford High School senior battling bile-duct cancer, is holding her own at Mott Children's Hospital at the University of Michigan, her mother said.
Sun Dec 01, 2013
Researchers unlock a new means of growing intestinal stem cells
Researchers at MIT and Brigham and Women's Hospital have shown that they can grow unlimited quantities of intestinal stem cells, then stimulate them to develop into nearly pure populations of different types of mature intestinal cells.
Fri Nov 29, 2013
Just Released: "Ulcerative Colitis Global Clinical Trials Review, H2, 2013"
This report provides elemental information and data relating to the clinical trials on Ulcerative Colitis.
Thu Nov 28, 2013
New drug provides hope for treating inflammatory bowel diseases
Over a million Americans suffer from inflammatory bowel diseases, such as Crohn's and ulcerative colitis.
Wed Nov 27, 2013
Novogen Files Suite of Patents for Anti-Tropomyosin Drug Technology;...
Below is a look at some of the headlines for companies that made news in the healthcare sector on November 26, 2013 .
Galapagos NV Announces GSK2586184 JAK1 Molecule Moves Into Phase 2 For Ulcerative Colitis
Galapagos NV announced today that GlaxoSmithKline plan to initiate an exploratory Phase 2 study with GSK2586184 in patients with ulcerative colitis, a third indication for this investigational molecule, in addition to psoriasis and lupus.
Louisiana woman overcomes eating disorder to complete her 20th marathon
It's 20 marathons and counting for a Jennings, Louisiana mom, once in the depths of extreme eating disorders and now recovery from a life-threatening digestive disease.
BRIEF-Galapagos says eligible to get 34 mln euro milestone payment from GSK
Galapagos NV : * Eligible to receive from GSK 34 million euros, and up to double-digit royalties on commercial sales of GSK2586184 * GSK to initiate exploratory phase 2 study with GSK2586184 in patients with ulcerative colitis * Ulcerative colitis is a third indication for this investigational molecule, in addition to psoriasis and lupus
Tue Nov 26, 2013
New Meds - New Hope for IBD
SAN DIEGO, Cali. 1.4 million Americans suffer from inflammatory bowel diseases like Crohn's and ulcerative colitis.
Immune Pharmaceuticals, Inc.'s Common Stock Approved For Trading On OMX First North Premier
A Company description has been prepared in accordance with First NorthA s rules and will be made available on ImmuneA s website.
Crohn's Disease Remission Lengthened In Kids, Teens With Anti-Inflammatory Drug Thalidomide
A group of Italian researchers have managed to extend and improve clinical remission among children and adolescents suffering from Crohn's disease, thanks to the once-daily anti-inflammatory drug, thalidomide.
BioLineRx Ltd. Announces New Positive Results In Phase 2a Trial For...
The histological and biochemical analyses of inflammation indicators reinforce the initial positive results of the study, reported in In order to perform the histological and biochemical analyses, biopsies were taken from trial participants before and after treatment.
Mon Nov 25, 2013
Fort Collins Coloradoan
Efforts aim to boost IBD and ostomy awareness
Lois Fink is a motivational speaker from Fort Collins who speaks and writes about her battle with Crohn's disease.
Sat Nov 23, 2013
Dietary iron does not impact the quality of life of patients with...
In animal models, excess luminal iron exacerbates colonic inflammation and cancer development.
Thu Nov 21, 2013
Nurses' Health Study: Activity may lower risk of Crohn's disease
Physical activity reduced the risk of developing Crohn's disease - but not ulcerative colitis - for participants in the Nurses' Health Study and the Nurses' Health Study II, according to a recent study.
Tue Nov 19, 2013
Edison Investment Research to Launch Coverage of Athersys
Trial results in Q114 for ulcerative colitis and Q214 for ischaemic stroke have the potential to re-rate the stock and enhance the company's options for fresh finance , although a newly secured two-year, is part of a programme of research initiations on bio technology companies exposed to global market opportunities.